CIM INVESTMENT MANAGEMENT INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2020$329,000
+20.5%
3,298
+38.9%
0.16%
+49.1%
Q4 2019$273,000
-2.5%
2,374
+7.0%
0.11%
+2.9%
Q3 2019$280,000
-60.2%
2,219
-72.4%
0.10%
-61.1%
Q1 2019$703,000
+11.2%
8,038
+27.2%
0.27%
-1.5%
Q4 2018$632,000
+16.0%
6,317
+32.9%
0.27%
+40.5%
Q3 2018$545,0004,7530.20%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders